Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Flower in connection with the acquisition of the energy storage facility Bredhälla from OX2
Mandate

Vinge has advised Flower in connection with the acquisition of the energy storage facility Bredhälla from OX2.

June 11, 2024 M&A Banking and Finance Environmental Law Commercial Agreements Real Estate and Construction FDI

The energy storage facility Bredhälla consists of batteries utilizing lithium-ion technology with a total capacity of 42,5MW /42,5MWh spread across 20 modules, making it the largest battery park in Sweden. Bredhälla will provide ancillary services to Svenska Kraftnät to ensure stability in the electricity grid and participate in wholesale markets by providing energy arbitrage.

The acquisition strengthens Flower’s position as the leading battery optimizer in Sweden.

Vinges team mainly consisted of Peter Sundgren and Gustav Wahlberg (M&A), Albert Wållgren and Jolinn Uhlin (Financing), Johan Cederblad and Lina Österberg (Environment), Jolene Reimersson and Carl Lexenberg (Commercial Agreements), Daniel Prawitz and Clara Klingspor (Construction) as well as Daniel Wendelsson, Felizia Wiker, Dagne Sabockis and Alva Chambert (FDI).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025